By Jessica Sier 
 

Novartis AG said Thursday that it will offer medicines on a zero-profit basis to financially-strained countries to assist in the treatment of Covid-19 symptoms.

The Swiss pharmaceuticals company said the initiative will include 15 medicines that help treat gastro-intestinal illness, acute respiratory symptoms, pneumonia and septic shock for low-income and lower-middle-income patients.

Novartis said the medicines will be made available to governments, non-governmental organizations and other institutional customers in up to 79 countries.

 

Write to Jessica Sier at jessica.sier@wsj.com

 

(END) Dow Jones Newswires

July 16, 2020 01:41 ET (05:41 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Grafico Azioni Novartis (NYSE:NVS)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Novartis
Grafico Azioni Novartis (NYSE:NVS)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Novartis